You are here

glioblastoma

Adastra Pharma’s Novel Glioma Therapy Achieves Positive Phase Ib Outcomes

Adastra Pharma’s Novel Glioma Therapy Achieves Positive Phase Ib Outcomes

BioSpace

clinical trials

Flag link:

Imvax raises $112M to advance brain cancer cell therapy

Imvax raises $112M to advance brain cancer cell therapy

Fierce Biotech

Flag link:

Bayer-backed Century buys Empirica to create brain cancer CAR-Ts

Bayer-backed Century buys Empirica to create brain cancer CAR-Ts

Fierce Biotech

Century Therapeutics

Flag link:

Early survival data boost Ziopharm's 'controlled IL-12' immunotherapy for glioblastoma

Early survival data boost Ziopharm's 'controlled IL-12' immunotherapy for glioblastoma

Endpoints

Ziopharm Oncology

Flag link:

Researchers ID 10 New Drug Targets for Aggressive Brain Cancer Glioblastoma

Researchers ID 10 New Drug Targets for Aggressive Brain Cancer Glioblastoma

BioSpace

drug development

Flag link:

Italian gene therapy player draws new investor from China for its answer to CAR-T relapses

Italian gene therapy player draws new investor from China for its answer to CAR-T relapses

Endpoints

Genenta Science

clinical trials

Multiple Myeloma

Flag link:

Bristol-Myers' (BMY) Opdivo Falls Flat in Brain Tumor Study

Bristol-Myers' (BMY) Opdivo Falls Flat in Brain Tumor Study

Yahoo/Zacks.com

Bristol-Myers Squibb

Flag link:

Strike three: Bristol-Myers’ third I/O shot at glioblastoma misses as Opdivo flops yet again on key endpoint

Strike three: Bristol-Myers’ third I/O shot at glioblastoma misses as Opdivo flops yet again on key endpoint

Endpoints

Bristol-Myers Squibb

clinical trials

Flag link:

Treating glioblastoma with a Ziopharm drug and IL-12 gene therapy

Treating glioblastoma with a Ziopharm drug and IL-12 gene therapy

Fierce Biotech

Ziopharm Oncology

clinical trials

Flag link:

Karyopharm drug tested in ‘industry-first’ approach to brain cancer

Karyopharm drug tested in ‘industry-first’ approach to brain cancer

Pharmaforum

clinical trials

Flag link:

AbbVie stock down 1.8% in premarket trade after failure of glioblastoma drug trial

AbbVie stock down 1.8% in premarket trade after failure of glioblastoma drug trial

Marketwatch

cilnical trials

Flag link:

Inovio Closes Enrollment in Brain Cancer Study Before Time

Inovio Closes Enrollment in Brain Cancer Study Before Time

Yahoo/Zacks.com

clinical trials

Flag link:

First Patient Treated Under Right to Try Law

First Patient Treated Under Right to Try Law

RAPS.org

Flag link:

Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial

Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial

CP Wire

Flag link:

Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial

Flag link:

Two papers open door to T cell brain entry for glioblastoma therapy

Two papers open door to T cell brain entry for glioblastoma therapy

BioCentury

Flag link:

Poliovirus treatment for glioblastoma posts 'encouraging' survival data, but work remains

Poliovirus treatment for glioblastoma posts 'encouraging' survival data, but work remains

Fierce Biotech

Duke University

Flag link:

Why ZIOPHARM Oncology, Inc. Stock Broke Out in May

Why ZIOPHARM Oncology, Inc. Stock Broke Out in May

Motley Fool

right-to-try laws

Flag link:

Northwest Bio's long-awaited glioblastoma vaccine data see stock roller coaster

Northwest Bio's long-awaited glioblastoma vaccine data see stock roller coaster

Fierce Biotech

Northwest Biotherapeutics

dendritic cell vaccines

clinical trials

Flag link:

Failure in pivotal PhIII brain cancer trial drags Israel’s VBL Therapeutics down

Failure in pivotal PhIII brain cancer trial drags Israel’s VBL Therapeutics down

Endpoints

clinical trials

VBL Therapeutics

Flag link:

Pages